- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00970424
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
September 9, 2011 updated by: Forest Laboratories
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus on Background Treatment With Pioglitazone
This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background treatment with pioglitazone.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
252
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mogilev, Belarus, 212030
- Forest Investigative Site 209
-
-
-
-
-
Dresden, Germany, 01099
- Forest Investigative Site 401
-
Dresden, Germany, 01307
- Forest Investigative Site 402
-
Mainz, Germany, 55116
- Forest Investigative Site 403
-
-
-
-
Andhra Pradesh
-
Vijayawada, Andhra Pradesh, India, 520002
- Forest Investigative Site 614
-
-
Gujarat
-
Ahmedabad, Gujarat, India, 380015
- Forest Investigative Site 618
-
-
Karnal
-
Haryana, Karnal, India, 132001
- Forest Investigative Site 620
-
-
Karnataka
-
Bangalore, Karnataka, India, 560003
- Forest Investigative Site 607
-
Bangalore, Karnataka, India, 560010
- Forest Investigative Site 606
-
Bangalore, Karnataka, India, 560043
- Forest Investigative Site 602
-
Bangalore, Karnataka, India, 560092
- Forest Investigative Site 604
-
Mangalore, Karnataka, India, 575003
- Forest Investigative Site 601
-
-
Maharashtra
-
Nagpur, Maharashtra, India, 440012
- Forest Investigative Site 616
-
Nasik, Maharashtra, India, 380015
- Forest Investigative Site 617
-
Pune, Maharashtra, India, 411037
- Forest Investigative Site 612
-
-
Tamil Nadu
-
Channi, Tamil Nadu, India, 600020
- Forest Investigative Site 603
-
Chennai, Tamil Nadu, India, 600013
- Forest Investigative Site 613
-
Vellore, Tamil Nadu, India, 632009
- Forest Investigative Site 615
-
-
-
-
Lithunia
-
Kaunas, Lithunia, Lithuania, 48259
- Forest Investigative Site 702
-
Kaunas, Lithunia, Lithuania, 49456
- Forest Investigative Site 703
-
Klaipeda, Lithunia, Lithuania, 92288
- Forest Investigative Site 704
-
Vilnius, Lithunia, Lithuania, 09112
- Forest Investigative Site 705
-
-
-
-
-
Bacau, Romania, 600164
- Forest Investigative Site 909
-
Bucuresti, Romania, 010584
- Forest Investigative Site 906
-
Bucuresti, Romania, 020725
- Forest Investigative Site 908
-
Satu Mare, Romania, 440055
- Forest Investigative Site 903
-
Sibiu, Romania, 550245
- Forest Investigative Site 901
-
Tg Mures, Romania, 540142
- Forest Investigative Site 905 Romania
-
Timisoara, Romania, 300736
- Forest Investigative Site 902
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- Forest Investigative Site 064
-
Birmingham, Alabama, United States, 35235
- Forest Investigative Site 020
-
-
Arizona
-
Chandler, Arizona, United States, 85225
- Forest Investigative Site 059
-
Litchfield, Arizona, United States, 85340
- Forest Investigative Site 096
-
Phoenix, Arizona, United States, 85020
- Forest Investigative Site 098
-
Scottsdale, Arizona, United States, 85254
- Forest Investigative Site 044
-
Tucson, Arizona, United States, 85741
- Forest Investigative Site 087
-
-
California
-
Anaheim, California, United States, 92801
- Forest Investigative Site 061
-
Chula Vista, California, United States, 91911
- Forest Investigative Site 041
-
Encinitas, California, United States, 92024
- Forest Investigative Site 049
-
Greenbrae, California, United States, 94904
- Forest Investigative Site 022
-
Harbor City, California, United States, 90710
- Forest Investigative Site 047
-
Huntington Park, California, United States, 90255
- Forest Investigative Site 010
-
Northridge, California, United States, 91325
- Forest Investigative Site 111
-
Riverside, California, United States, 92506
- Forest Investigative Site 031
-
Roseville, California, United States, 95661
- Forest Investigative Site 091
-
Sacramento, California, United States, 95821
- Forest Investigative Site 067
-
Santa Ana, California, United States, 92701
- Forest Investigative Site 112
-
Walnut Creek, California, United States, 94598
- Forest Investigative Site 011
-
West Hills, California, United States, 91307
- Forest Investigative Site 063
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80910
- Forest Investigative Site 115
-
-
Florida
-
Clearwater, Florida, United States, 33765
- Forest Investigative Site 073
-
Daytona Beach, Florida, United States, 32117
- Forest Investigative Site 004
-
DeLand, Florida, United States, 32720
- Forest Investigative Site 052
-
Jacksonville, Florida, United States, 32205
- Forest Investigative Site 062
-
Miami, Florida, United States, 33169
- Forest Investigative Site 021
-
Miami, Florida, United States, 33186
- Forest Investigative Site 122
-
Miami, Florida, United States, 33183
- Forest Investigative Site 050
-
Orlando, Florida, United States, 32806
- Forest Investigative Site 015
-
Sarasota, Florida, United States, 34239
- Forest Investigative Site 018
-
St. Petersburg, Florida, United States, 33716
- Forest Investigative Site 075
-
West Palm Beach, Florida, United States, 33401
- Forest Investigative Site 026
-
-
Georgia
-
Atlanta, Georgia, United States, 30338
- Forest Investigative Site 045
-
Augusta, Georgia, United States, 30909
- Forest Investigative Site 079
-
-
Idaho
-
Meridian, Idaho, United States, 83646
- Forest Investigative Site 009
-
-
Illinois
-
Melrose Park, Illinois, United States, 60160
- Forest Investigative Site 60
-
Peoria, Illinois, United States, 61614
- Forest Investigative Site 030
-
-
Indiana
-
Evansville, Indiana, United States, 47710
- Forest Investigative Site 100
-
Evansville, Indiana, United States, 47713
- Forest Investigative Site 097
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- Forest Investigative Site 053
-
Wichita, Kansas, United States, 67203
- Forest Investigative Site 008
-
-
Kentucky
-
Erlanger, Kentucky, United States, 41018
- Forest Investigative Site 078
-
Madisonville, Kentucky, United States, 42431
- Forest Investigative Site 024
-
-
Louisiana
-
Covington, Louisiana, United States, 70433
- Forest Investigative Site 034
-
-
Maryland
-
Baltimore, Maryland, United States, 21204
- Forest Investigative Site 035
-
Oxon Hill, Maryland, United States, 20745
- Forest Investigative Site 046
-
-
Massachusetts
-
New Bedford, Massachusetts, United States, 02740
- Forest Investigative Site 118
-
Waltham, Massachusetts, United States, 02453
- Forest Investigative Site 007
-
-
Michigan
-
Dearborn, Michigan, United States, 48126
- Forest Investigative Site 002
-
St. Clair Shores, Michigan, United States, 48081
- Forest Investigative Site 029
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Forest Investigative Site 054
-
-
Nebraska
-
Grand Island, Nebraska, United States, 68803
- Forest Investigative Site 013
-
-
Nevada
-
Las Vegas, Nevada, United States, 89101
- Forest Investigative Site 072
-
Las Vegas, Nevada, United States, 89117
- Forest Investigative Site 065
-
-
New York
-
New Hyde Park, New York, United States, 11042
- Forest Investigative Site 081
-
New York, New York, United States, 10019
- Forest Investigative Site 016
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Forest Investigative Site 094
-
Charlotte, North Carolina, United States, 28209
- Forest Investigative Site 051
-
Charlotte, North Carolina, United States, 28277
- Forest Investigative Site 117
-
Lenoir, North Carolina, United States, 28645
- Forest Investigative Site 058
-
Morehead City, North Carolina, United States, 28557
- Forest Investigative Site 038
-
Salisbury, North Carolina, United States, 28144
- Forest Investigative Site 040
-
-
Ohio
-
Akron, Ohio, United States, 44311
- Forest Investigative Site 039
-
Cincinnati, Ohio, United States, 45242
- Forest Investigative Site 023
-
Columbus, Ohio, United States, 43201
- Forest Investigative Site 043
-
Dayton, Ohio, United States, 45406
- Forest Investigative Site 057
-
Kettering, Ohio, United States, 45429
- Forest Investigative Site 032
-
-
Oklahoma
-
Norman, Oklahoma, United States, 73069
- Forest Investigative Site 149
-
-
Oregon
-
Ashland, Oregon, United States, 97520
- Forest Investigative Site 102
-
Eugene, Oregon, United States, 97404
- Forest Investigative Site 005
-
-
Pennsylvania
-
Harleysville, Pennsylvania, United States, 19438
- Forest Investigative Site 037
-
Philadelphia, Pennsylvania, United States, 19152
- Forest Investigative Site 066
-
Tipton, Pennsylvania, United States, 16684
- Forest Investigative Site 036
-
-
South Carolina
-
Greer, South Carolina, United States, 29651
- Forest Investigative Site 103
-
Manning, South Carolina, United States, 29102
- Forest Investigative Site 090
-
Pelzer, South Carolina, United States, 29669
- Forest Investigative Site 033
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Forest Investigative Site 114
-
Chattanooga, Tennessee, United States, 37421
- Forest Investigative Site 104
-
-
Texas
-
Arlington, Texas, United States, 76014
- Forest Investigative Site 099
-
Corpus Christi, Texas, United States, 78404
- Forest Investigative Site 056
-
Dallas, Texas, United States, 75235
- Forest Investigative Site 017
-
Dallas, Texas, United States, 75251
- Forest Investigative Site 124
-
Houston, Texas, United States, 77079
- Forest Investigative Site 106
-
Irving, Texas, United States, 75039
- Forest Investigative Site 014
-
San Antonio, Texas, United States, 78229
- Forest Investigative Site 109
-
-
Utah
-
Salt Lake City, Utah, United States, 84107
- Forest Investigative Site 076
-
-
Virginia
-
Virginia Beach, Virginia, United States, 23454
- Forest Investigative Site 028
-
-
Washington
-
Spokane, Washington, United States, 99207
- Forest Investigative Site 092
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53209
- Forest Investigative Site 027
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 2 diabetes mellitus, diagnosed at least 3 months prior to Screening (Visit 1)
- BMI 20 to 48 kg/m2, inclusive
- HbA1c 7.0% - 10.0%, inclusive
- Age 18 to 85 years, inclusive
Exclusion Criteria:
- Currently taking more than one oral hypoglycemic agent
- Type 1 diabetes mellitus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 1
placebo, oral tablet administered once daily on background of pioglitazone
|
placebo, oral tablet administered once daily on background of pioglitazone
|
|
Experimental: 2
dutogliptin, oral tablet administered once daily on background of pioglitazone
|
dutogliptin, oral tablet administered once daily on background of pioglitazone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hemoglobin A1c Level (HbA1c)
Time Frame: HbA1c is drawn at Visit 1 (Week -16 to -4), Visit 3 (Week -2), Visit 4 (Week 0), Visit 5 (Week 4), Visit 6 (Week 10), Visit 7 (Week 18) and Week 8 (Week 26)
|
HbA1c is drawn at Visit 1 (Week -16 to -4), Visit 3 (Week -2), Visit 4 (Week 0), Visit 5 (Week 4), Visit 6 (Week 10), Visit 7 (Week 18) and Week 8 (Week 26)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fasting Plasma Glucose Level (FPG)
Time Frame: FPG is drawn at Visit 1 (Week -16 to -4), Visit 2 (Week -4), Visit 3 (Week -2), Visit 4 (Week 0), Visit 5 (Week 4), Visit 6 (Week 10), Visit 7 (Week 18) and Visit 8 (Week 26).
|
FPG is drawn at Visit 1 (Week -16 to -4), Visit 2 (Week -4), Visit 3 (Week -2), Visit 4 (Week 0), Visit 5 (Week 4), Visit 6 (Week 10), Visit 7 (Week 18) and Visit 8 (Week 26).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Kaity Posada, PharmD, Forest Research Institute, a Subsidiary of Forest Laboratories, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
August 1, 2010
Study Registration Dates
First Submitted
September 1, 2009
First Submitted That Met QC Criteria
September 1, 2009
First Posted (Estimate)
September 2, 2009
Study Record Updates
Last Update Posted (Estimate)
September 21, 2011
Last Update Submitted That Met QC Criteria
September 9, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DUT-MD-304
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type II
-
University of Malagaclinical professorNot yet recruiting
-
pico-tesla Magnetic Therapies, LLCCompletedType II Diabetes MellitusUnited States
-
KeyBioscience AGEli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...TerminatedType II Diabetes MellitusGermany
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
HealthInsightCenter for Technology and Aging; VoxivaUnknownType II Diabetes MellitusUnited States
-
Baqai Institute of Diabetology and EndocrinologyNational Institute for Health Research, United Kingdom; University of York; Aga... and other collaboratorsRecruitingType II Diabetes MellitusPakistan
-
University of PretoriaNestlè Nutrition Institute Africa; South African Sugar AssociationCompletedDiabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] UncontrolledSouth Africa
-
Microbio Co LtdCompleted
-
University of PrimorskaUniversity of Ljubljana School of Medicine, SloveniaCompletedDiabetes Mellitus Type II,Slovenia
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States